Influenza A H3 BY PCR

The Influenza A H3 BY PCR test is a molecular diagnostic that detects RNA from the Influenza A virus H3 subtype using real-time reverse transcription PCR (RT‑PCR). It identifies active infection with high sensitivity and specificity from respiratory swab specimens, confirming the presence of the H3 strain rather than providing antibody or past-infection status.

This test is important for accurate clinical diagnosis, timely initiation of antiviral therapy, and infection-control decisions—especially during seasonal outbreaks or in healthcare settings. Offered with trained home sample collection and lab-certified reporting, it is convenient for residents in Dubai who need rapid, reliable confirmation of suspected influenza A (H3) infection.

• Influenza A (H3) viral RNA (RT‑PCR)
• Cycle threshold (Ct) value
• Internal control / sample adequacy
• Qualitative result: Detected / Not Detected

• Onset of influenza-like symptoms (fever, cough, sore throat, body aches)
• Within the first 1–7 days of symptom onset for best sensitivity
• Severe respiratory illness or worsening symptoms requiring medical assessment
• High-risk individuals (elderly, pregnant women, chronic disease, immunocompromised)
• Known exposure, outbreak investigation, or pre-admission screening

• High-sensitivity confirmation of Influenza A H3 subtype
• Fast, lab-certified results to guide clinical treatment and isolation
• Home sample collection by trained staff for patient convenience
• Supports timely public-health reporting and outbreak management in Dubai
• Helps clinicians decide on antiviral therapy and reduce unnecessary antibiotics

• Nasopharyngeal or oropharyngeal swab collected by a trained healthcare professional
• No fasting required; best sampled within 1–7 days of symptom onset
• Provide valid Emirates ID or passport at time of collection and confirm appointment
• Keep specimen refrigerated if instructed and follow courier/collection guidance for timely transport